A Phase 1 Study with a Novel Oral Fulvestrant Formulation.

• Research type

  Research Study

• Full title

  A Phase 1 Study with a Novel Oral Fulvestrant Formulation.

• IRAS ID

  166348

• Contact name

  Katalin Ferenczi

• Sponsor organisation

  Druggability Technologies Holdings Ltd

• Eudract number

  2014-004218-28

• Duration of Study in the UK

  0 years, 2 months, 21 days

• Research summary

  Research summary not yet available

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  14/NW/1422

• Date of REC Opinion

  19 Dec 2014

• REC opinion

  Further Information Favourable Opinion